Phylogenetics Sheds Light on Crime

Researchers reconstructed the evolutionary histories of hepatitis C virus samples to confirm that a Spanish anesthesiologist infected 275 of his patients.

Written byKate Yandell
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

FLICKR, KENNY HOLSTONBetween 1988 and 1997, an anesthesiologist from Valencia, Spain, infected 275 of his patients with the hepatitis C virus, according to Spanish courts. Earlier this month (July 19), researchers from University of Valencia who helped establish the timing and victims of the outbreak for the courts published their account of the case in BMC Biology.

The anesthesiologist, Juan Maeso, is believed to have been infected with the blood-borne virus himself and then to have spread the infection by injecting himself with painkillers from the same needles he used to inject his patients.

Epidemiological data linked the anesthesiologist to 322 hepatitis C-positive patients. The researchers sequenced a rapidly evolving area of the hepatitis C genome, the E1-E2 region, in samples from the anesthesiologist and his putative victims. As a control, they also sequenced hepatitis C samples from 44 hepatitis C-infected people who were believed not to have been involved in the outbreak.

A phylogenetic tree of the viral sequences suggested that the majority of the patients’ viruses were derived from the anesthesiologist, excluding viruses from the control group and 47 additional ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies